NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) Fundamental Analysis & Valuation

NASDAQ:NEWTI • US6525268073

Current stock price

25.48 USD
+0.02 (+0.08%)
Last:

This NEWTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. NEWTI Profitability Analysis

1.1 Basic Checks

  • In the past year NEWTI was profitable.
  • In the past year NEWTI has reported a negative cash flow from operations.
  • Each year in the past 5 years NEWTI has been profitable.
  • NEWTI had negative operating cash flow in 4 of the past 5 years.
NEWTI Yearly Net Income VS EBIT VS OCF VS FCFNEWTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.12%, NEWTI is in line with its industry, outperforming 58.59% of the companies in the same industry.
  • NEWTI's Return On Equity of 14.63% is fine compared to the rest of the industry. NEWTI outperforms 73.74% of its industry peers.
  • NEWTI's Return On Invested Capital of 4.06% is in line compared to the rest of the industry. NEWTI outperforms 58.59% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NEWTI is below the industry average of 8.00%.
  • The last Return On Invested Capital (4.06%) for NEWTI is above the 3 year average (3.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.12%
ROE 14.63%
ROIC 4.06%
ROA(3y)2.57%
ROA(5y)3.78%
ROE(3y)16.56%
ROE(5y)15.82%
ROIC(3y)3.79%
ROIC(5y)5.19%
NEWTI Yearly ROA, ROE, ROICNEWTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of NEWTI (18.80%) is better than 77.78% of its industry peers.
  • In the last couple of years the Profit Margin of NEWTI has declined.
  • Looking at the Operating Margin, with a value of 46.39%, NEWTI belongs to the top of the industry, outperforming 83.84% of the companies in the same industry.
  • NEWTI's Operating Margin has declined in the last couple of years.
  • NEWTI has a Gross Margin of 94.25%. This is amongst the best in the industry. NEWTI outperforms 95.96% of its industry peers.
Industry RankSector Rank
OM 46.39%
PM (TTM) 18.8%
GM 94.25%
OM growth 3Y-4.87%
OM growth 5Y-4.75%
PM growth 3Y-5.91%
PM growth 5Y-10.33%
GM growth 3YN/A
GM growth 5YN/A
NEWTI Yearly Profit, Operating, Gross MarginsNEWTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

0

2. NEWTI Health Analysis

2.1 Basic Checks

  • NEWTI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, NEWTI has more shares outstanding
  • Compared to 5 years ago, NEWTI has more shares outstanding
  • NEWTI has about the same debt/assets ratio as last year.
NEWTI Yearly Shares OutstandingNEWTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NEWTI Yearly Total Debt VS Total AssetsNEWTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.02, we must say that NEWTI is in the distress zone and has some risk of bankruptcy.
  • NEWTI has a worse Altman-Z score (-0.02) than 61.62% of its industry peers.
  • A Debt/Equity ratio of 5.63 is on the high side and indicates that NEWTI has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 5.63, NEWTI is doing worse than 80.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.63
Debt/FCF N/A
Altman-Z -0.02
ROIC/WACC0.64
WACC6.35%
NEWTI Yearly LT Debt VS Equity VS FCFNEWTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

2.3 Liquidity

  • NEWTI has a Current Ratio of 0.19. This is a bad value and indicates that NEWTI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NEWTI's Current ratio of 0.19 is on the low side compared to the rest of the industry. NEWTI is outperformed by 68.69% of its industry peers.
  • A Quick Ratio of 0.19 indicates that NEWTI may have some problems paying its short term obligations.
  • NEWTI has a worse Quick ratio (0.19) than 68.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
NEWTI Yearly Current Assets VS Current LiabilitesNEWTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

6

3. NEWTI Growth Analysis

3.1 Past

  • The earnings per share for NEWTI have decreased strongly by -50.26% in the last year.
  • NEWTI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.98% yearly.
  • The Revenue has grown by 13.34% in the past year. This is quite good.
  • NEWTI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.47% yearly.
EPS 1Y (TTM)-50.26%
EPS 3Y-23.3%
EPS 5Y-13.98%
EPS Q2Q%-5.8%
Revenue 1Y (TTM)13.34%
Revenue growth 3Y29.32%
Revenue growth 5Y24.47%
Sales Q2Q%-4.6%

3.2 Future

  • Based on estimates for the next years, NEWTI will show a very strong growth in Earnings Per Share. The EPS will grow by 46.82% on average per year.
  • The Revenue is expected to grow by 13.39% on average over the next years. This is quite good.
EPS Next Y144.13%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
EPS Next 5YN/A
Revenue Next Year14.33%
Revenue Next 2Y13.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NEWTI Yearly Revenue VS EstimatesNEWTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
NEWTI Yearly EPS VS EstimatesNEWTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. NEWTI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 26.27, NEWTI can be considered very expensive at the moment.
  • NEWTI's Price/Earnings ratio is a bit more expensive when compared to the industry. NEWTI is more expensive than 61.62% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.53. NEWTI is around the same levels.
  • With a Price/Forward Earnings ratio of 10.76, the valuation of NEWTI can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NEWTI is on the same level as its industry peers.
  • NEWTI is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.27
Fwd PE 10.76
NEWTI Price Earnings VS Forward Price EarningsNEWTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • NEWTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NEWTI is cheaper than 70.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.82
NEWTI Per share dataNEWTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as NEWTI's earnings are expected to grow with 46.82% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y61.36%
EPS Next 3Y46.82%

5

5. NEWTI Dividend Analysis

5.1 Amount

  • NEWTI has a Yearly Dividend Yield of 6.30%, which is a nice return.
  • NEWTI's Dividend Yield is rather good when compared to the industry average which is at 1.86. NEWTI pays more dividend than 94.95% of the companies in the same industry.
  • NEWTI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.3%

5.2 History

  • The dividend of NEWTI decreases each year by -12.63%.
  • NEWTI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)-12.63%
Div Incr Years0
Div Non Decr Years2
NEWTI Yearly Dividends per shareNEWTI Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • NEWTI pays out 48.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP48.2%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
NEWTI Yearly Income VS Free CF VS DividendNEWTI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M
NEWTI Dividend Payout.NEWTI Dividend Payout, showing the Payout Ratio.NEWTI Dividend Payout.PayoutRetained Earnings

NEWTI Fundamentals: All Metrics, Ratios and Statistics

NEWTEKONE INC - NEWT 8 09/01/28

NASDAQ:NEWTI (4/14/2026, 8:00:02 PM)

25.48

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)01-29
Earnings (Next)04-30
Inst Owners44.35%
Inst Owner ChangeN/A
Ins Owners6.09%
Ins Owner ChangeN/A
Market Cap735.86M
Revenue(TTM)309.46M
Net Income(TTM)58.18M
Analysts73.85
Price Target38.5 (51.1%)
Short Float %0.01%
Short Ratio0.69
Dividend
Industry RankSector Rank
Dividend Yield 6.3%
Yearly Dividend1.02
Dividend Growth(5Y)-12.63%
DP48.2%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.13%
Min EPS beat(2)-6.52%
Max EPS beat(2)2.25%
EPS beat(4)1
Avg EPS beat(4)-59.57%
Min EPS beat(4)-230.76%
Max EPS beat(4)2.25%
EPS beat(8)5
Avg EPS beat(8)-22.65%
EPS beat(12)7
Avg EPS beat(12)-14.64%
EPS beat(16)9
Avg EPS beat(16)-15.55%
Revenue beat(2)0
Avg Revenue beat(2)-8.96%
Min Revenue beat(2)-10.14%
Max Revenue beat(2)-7.77%
Revenue beat(4)1
Avg Revenue beat(4)-2.02%
Min Revenue beat(4)-10.14%
Max Revenue beat(4)16.67%
Revenue beat(8)5
Avg Revenue beat(8)2.8%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.65%
PT rev (3m)21.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.91%
EPS NY rev (1m)0%
EPS NY rev (3m)3.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.54%
Valuation
Industry RankSector Rank
PE 26.27
Fwd PE 10.76
P/S 2.38
P/FCF N/A
P/OCF N/A
P/B 1.85
P/tB 1.92
EV/EBITDA 8.82
EPS(TTM)0.97
EY3.81%
EPS(NY)2.37
Fwd EY9.29%
FCF(TTM)-20.41
FCFYN/A
OCF(TTM)-20.06
OCFYN/A
SpS10.72
BVpS13.77
TBVpS13.26
PEG (NY)0.18
PEG (5Y)N/A
Graham Number17.3335 (-31.97%)
Profitability
Industry RankSector Rank
ROA 2.12%
ROE 14.63%
ROCE 11.69%
ROIC 4.06%
ROICexc 4.55%
ROICexgc 5.05%
OM 46.39%
PM (TTM) 18.8%
GM 94.25%
FCFM N/A
ROA(3y)2.57%
ROA(5y)3.78%
ROE(3y)16.56%
ROE(5y)15.82%
ROIC(3y)3.79%
ROIC(5y)5.19%
ROICexc(3y)4.39%
ROICexc(5y)5.63%
ROICexgc(3y)4.84%
ROICexgc(5y)7.65%
ROCE(3y)9.67%
ROCE(5y)9.69%
ROICexgc growth 3Y-22.07%
ROICexgc growth 5Y-10.94%
ROICexc growth 3Y-11.48%
ROICexc growth 5Y-4.52%
OM growth 3Y-4.87%
OM growth 5Y-4.75%
PM growth 3Y-5.91%
PM growth 5Y-10.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 5.63
Debt/FCF N/A
Debt/EBITDA 15.52
Cap/Depr 1530.84%
Cap/Sales 3.3%
Interest Coverage 1.47
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -0.02
F-Score3
WACC6.35%
ROIC/WACC0.64
Cap/Depr(3y)523.78%
Cap/Depr(5y)314.27%
Cap/Sales(3y)1.23%
Cap/Sales(5y)0.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.26%
EPS 3Y-23.3%
EPS 5Y-13.98%
EPS Q2Q%-5.8%
EPS Next Y144.13%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
EPS Next 5YN/A
Revenue 1Y (TTM)13.34%
Revenue growth 3Y29.32%
Revenue growth 5Y24.47%
Sales Q2Q%-4.6%
Revenue Next Year14.33%
Revenue Next 2Y13.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.11%
EBIT growth 3Y23.02%
EBIT growth 5Y18.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-280.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-274.97%
OCF growth 3YN/A
OCF growth 5YN/A

NEWTEKONE INC - NEWT 8 09/01/28 / NEWTI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEWTEKONE INC - NEWT 8 09/01/28?

ChartMill assigns a fundamental rating of 4 / 10 to NEWTI.


What is the valuation status of NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) stock?

ChartMill assigns a valuation rating of 4 / 10 to NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI). This can be considered as Fairly Valued.


What is the profitability of NEWTI stock?

NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for NEWTI stock?

The Price/Earnings (PE) ratio for NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) is 26.27 and the Price/Book (PB) ratio is 1.85.


How financially healthy is NEWTEKONE INC - NEWT 8 09/01/28?

The financial health rating of NEWTEKONE INC - NEWT 8 09/01/28 (NEWTI) is 0 / 10.